Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 1
2002 4
2003 2
2004 1
2005 2
2006 1
2007 2
2008 6
2009 2
2010 6
2011 4
2012 6
2013 2
2014 5
2015 13
2016 7
2017 4
2018 4
2019 2
2020 1
2021 7
2022 3
2023 6
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S, Pautas C, Terré C, Raffoux E, Bordessoule D, Bastie JN, Legrand O, Thomas X, Turlure P, Reman O, de Revel T, Gastaud L, de Gunzburg N, Contentin N, Henry E, Marolleau JP, Aljijakli A, Rousselot P, Fenaux P, Preudhomme C, Chevret S, Dombret H; Acute Leukemia French Association. Castaigne S, et al. Among authors: contentin n. Lancet. 2012 Apr 21;379(9825):1508-16. doi: 10.1016/S0140-6736(12)60485-1. Epub 2012 Apr 5. Lancet. 2012. PMID: 22482940 Clinical Trial.
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Chevallier P, Leguay T, Delord M, Salek C, Kim R, Huguet F, Hicheri Y, Wartiovaara-Kautto U, Raffoux E, Cluzeau T, Balsat M, Roth-Guepin G, Tavernier E, Lepretre S, Bilger K, Bergugnat H, Berceanu A, Alexis M, Doubek M, Brissot E, Hunault-Berger M, Lebon D, Turlure P, Chantepie S, Belhabri A, Wickenhauser S, Bastie JN, Cacheux V, Himberlin C, Banos A, Gardin C, Bonnet S, Plantier I, Pica GM, Escoffre-Barbe M, Boissel N, Dombret H, Clappier E, Rousselot P; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) and the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL). Chevallier P, et al. J Clin Oncol. 2024 Dec 20;42(36):4327-4341. doi: 10.1200/JCO.24.00490. Epub 2024 Oct 17. J Clin Oncol. 2024. PMID: 39418626 Clinical Trial.
[Imatinib-induced DRESS].
Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, Joly P. Goldman J, et al. Among authors: contentin n. Ann Dermatol Venereol. 2008 May;135(5):393-6. doi: 10.1016/j.annder.2007.10.007. Epub 2008 Apr 21. Ann Dermatol Venereol. 2008. PMID: 18457727 French.
Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity.
Moreno-Arciniegas A, García A, Kelm M, D'Amore F, da Silva MG, Sánchez-González J, Sánchez PL, López-Fernández T, Córdoba R, Asteggiano R, Camus V, Smink J, Ferreira A, Kersten MJ, Bolaños N, Escalera N, Pacella E, Gómez-Talavera S, Quesada A, Rosselló X, Ibanez B; RESILIENCE Trial Investigators. Moreno-Arciniegas A, et al. Eur J Heart Fail. 2024 Oct;26(10):2213-2222. doi: 10.1002/ejhf.3395. Epub 2024 Aug 30. Eur J Heart Fail. 2024. PMID: 39212445 Free article.
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT.
Perruccio K, Ward KN, Tridello G, Knelange N, Zeiser R, Franke GN, Sirvent A, Einsele H, Vicent MG, Navarro JMF, Contentin N, Collin M, Martino R, Gambella M, Sengeloev H, Passweg J, Snowden J, Nagler A, Kulagin A, Gabriel M, Kröger N, Pascual Cascon MJ, Yeshurun M, Güngör T, Robin C, Clark A, Lopez Duarte M, Amor AA, Itala-Remes M, Mikulska M, Styczynski J, de la Camara R, Ljungman P, Averbuch D, Cesaro S. Perruccio K, et al. Among authors: contentin n. Bone Marrow Transplant. 2025 Sep;60(9):1243-1248. doi: 10.1038/s41409-025-02638-7. Epub 2025 Jun 3. Bone Marrow Transplant. 2025. PMID: 40461849 Free article.
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Kaphan E, Bettega F, Vallet N, Fegueux N, Robin M, Bazarbachi A, Nguyen S, Beauvais D, Forcade E, De Oca MCM, Devillier R, Chevallier P, Loschi M, Huynh A, Bay JO, Rubio MT, Suarez F, Francois S, Poire X, Contentin N, Desmier D, Charbonnier A, Cornillon J, Chantepie S, Turlure P, Bulabois CE, Michonneau D, Villate A, Sfgm-Tc. Kaphan E, et al. Among authors: contentin n. Haematologica. 2024 Oct 1;109(10):3373-3378. doi: 10.3324/haematol.2024.284968. Haematologica. 2024. PMID: 38867585 Free PMC article. No abstract available.
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT.
Esteve J, Nagler A, Labopin M, Versluis J, Sanz J, Gedde-Dahl T, Burns D, Roeven M, Labussière-Wallet H, von dem Borne P, van Gorkom G, Contentin N, Neubauer A, Wagner-Drouet EM, Kröger N, Mohty M, Ciceri F. Esteve J, et al. Among authors: contentin n. Am J Hematol. 2025 Jun;100(6):954-962. doi: 10.1002/ajh.27647. Epub 2025 Mar 10. Am J Hematol. 2025. PMID: 40062532
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
Maaziz N, Garrec C, Airaud F, Bobée V, Contentin N, Cayssials E, Rimbert A, Aral B, Bézieau S, Gardie B, Girodon F. Maaziz N, et al. Among authors: contentin n. Genes (Basel). 2023 May 11;14(5):1066. doi: 10.3390/genes14051066. Genes (Basel). 2023. PMID: 37239426 Free PMC article.
Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.
Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, Tazi A. Bergeron A, et al. Among authors: contentin n. Am J Respir Crit Care Med. 2015 Jun 1;191(11):1242-9. doi: 10.1164/rccm.201410-1818OC. Am J Respir Crit Care Med. 2015. PMID: 25835160 Clinical Trial.
85 results